+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ertapenem Sodium for Injection Market - Global Forecast 2025-2030- Product Image
Ertapenem Sodium for Injection Market - Global Forecast 2025-2030- Product Image
Sale

Ertapenem Sodium for Injection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137603
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Ertapenem Sodium for Injection market is evolving as healthcare providers demand advanced, highly effective therapies for complex infections across both hospital and outpatient care. This landscape is shaped by rising antimicrobial resistance, sophisticated dosing protocols, and new challenges from tariff policies affecting production and supply.

Market Snapshot

Ertapenem Sodium for Injection delivers a broad-spectrum solution for Gram-negative and Gram-positive pathogens, meeting the needs of today's clinical and operational environments. The market benefits from its once-daily dosing, which reduces nursing time and potential for error, while its extended half-life suits both inpatient and ambulatory settings. Adoption has expanded from high-acuity hospitals into ambulatory surgical centers and specialized clinics, indicating a shift toward integrated infection management across care sites. With robust interest from both established and emerging markets, stakeholders are closely monitoring growth drivers, including the role of infusible antibiotics, technology-enabled outpatient solutions, and evolving supply chain models.

Scope & Segmentation

This report delivers an in-depth analysis of the Ertapenem Sodium for Injection market across key segments:

  • End User: Ambulatory surgical centers, general clinics, specialty clinics, private hospitals, and public hospitals.
  • Application: Acute pelvic infections, community-acquired pneumonia, complicated intra-abdominal infections, and complicated skin and skin structure infections—each mapped across hospital and outpatient use.
  • Strength: 1G vial and 2G vial, chosen according to clinical severity and patient profile.
  • Distribution Channel: Hospital pharmacies (in-house and third-party managed), online pharmacies (direct-to-consumer and marketplace), and retail pharmacies (chain and independent).
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, and multiple additional markets), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and others).
  • Key Companies: Merck & Co., Sandoz AG, Fresenius Kabi AG, Pfizer Inc., Teva Pharmaceutical Industries Limited, Viatris Inc., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Limited, Lupin Limited, and Sun Pharmaceutical Industries Limited.
[ImageId=GUID1]

Key Takeaways

  • The market is experiencing a paradigm shift as Ertapenem Sodium for Injection transitions from exclusive hospital use to broader outpatient and ambulatory clinic settings, facilitating improved infection management and patient throughput.
  • Technological advances, such as smart infusion pumps and real-time digital monitoring, support safe administration and strengthen prescriber-to-patient feedback loops. These trends bolster medication adherence and stewardship initiatives.
  • Segmented end user needs are driving tailored solutions, with strength variations (1G and 2G vials) supporting differentiated inventory and procurement strategies across site types and patient acuity levels.
  • Collaboration between global manufacturers and local partners supports market expansion, resilience against trade disruptions, and regional adaptation of Ertapenem Sodium use.
  • New United States tariff measures in 2025 are increasing raw material costs, logistics fees, and inventory management challenges, prompting manufacturers and healthcare providers to renegotiate supply agreements and optimize sourcing.
[ImageId=GUID2]

Tariff Impact on Supply Chain Dynamics

Recent U.S. tariff policies have introduced higher import duties on active ingredients and excipients essential for Ertapenem Sodium for Injection. This is raising production expenses and challenging just-in-time inventory models, leading industry participants to adopt strategies such as vertical integration, enhanced safety stocks, and collective purchasing to maintain patient access and margin sustainability.

Methodology & Data Sources

This analysis combines a review of leading peer-reviewed publications, regulatory archives, and clinical guidelines with expert interviews from infectious disease specialists, pharmacists, and procurement managers. Insights are triangulated using both primary and secondary sources, and findings undergo peer review and quality assurance to ensure accuracy and actionable value.

Why This Report Matters

  • Supports strategic planning by evaluating clinical, operational, and regulatory factors affecting Ertapenem Sodium for Injection adoption across diverse care settings.
  • Guides sourcing and supply partners through the latest tariff impacts on margin, logistics, and procurement optimization.
  • Enables senior decision-makers to identify region- or segment-specific growth avenues using up-to-date, multi-source validated insights.

Conclusion

Ertapenem Sodium for Injection is at the center of evolving infection management strategies as clinical protocols, technology, and supply chains adapt. This report provides a vital resource for decision-makers focused on optimizing patient outcomes and organizational resilience in a rapidly changing antimicrobial landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing prevalence of multidrug resistant Gram negative infections driving higher ertapenem adoption
5.2. Pipeline advancements in novel subcutaneously delivered ertapenem formulations to enhance outpatient management
5.3. Regulatory approvals for expanded ertapenem pediatric indications to address rising childhood infection rates
5.4. Strategic partnerships between pharmaceutical firms to co develop high quality ertapenem generics for niche markets
5.5. Innovations in extended infusion technologies improving serum concentration and therapeutic efficacy of ertapenem
5.6. Rising cost pressures on hospitals driving preference for cost effective ertapenem procurement strategies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ertapenem Sodium for Injection Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Center
8.3. Clinic
8.3.1. General Clinic
8.3.2. Specialty Clinic
8.4. Hospital
8.4.1. Private Hospital
8.4.2. Public Hospital
9. Ertapenem Sodium for Injection Market, by Application
9.1. Introduction
9.2. Acute Pelvic Infections
9.2.1. Hospital Administered
9.2.2. Outpatient Use
9.3. Community-Acquired Pneumonia
9.3.1. Hospital Administered
9.3.2. Outpatient Use
9.4. Complicated Intra-Abdominal Infections
9.4.1. Hospital Administered
9.4.2. Outpatient Use
9.5. Complicated Skin And Skin Structure Infections
9.5.1. Hospital Administered
9.5.2. Outpatient Use
10. Ertapenem Sodium for Injection Market, by Strength
10.1. Introduction
10.2. 1G Vial
10.3. 2G Vial
11. Ertapenem Sodium for Injection Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. In-House Pharmacy
11.2.2. Third-Party Managed
11.3. Online Pharmacies
11.3.1. Direct-To-Consumer
11.3.2. Marketplace
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Americas Ertapenem Sodium for Injection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Ertapenem Sodium for Injection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Ertapenem Sodium for Injection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Merck & Co., Inc.
15.3.2. Sandoz AG
15.3.3. Fresenius Kabi AG
15.3.4. Pfizer Inc.
15.3.5. Teva Pharmaceutical Industries Limited
15.3.6. Viatris Inc.
15.3.7. Hikma Pharmaceuticals PLC
15.3.8. Dr. Reddy’s Laboratories Limited
15.3.9. Lupin Limited
15.3.10. Sun Pharmaceutical Industries Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ERTAPENEM SODIUM FOR INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ERTAPENEM SODIUM FOR INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ERTAPENEM SODIUM FOR INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ERTAPENEM SODIUM FOR INJECTION MARKET: RESEARCHAI
FIGURE 24. ERTAPENEM SODIUM FOR INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. ERTAPENEM SODIUM FOR INJECTION MARKET: RESEARCHCONTACTS
FIGURE 26. ERTAPENEM SODIUM FOR INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ERTAPENEM SODIUM FOR INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY OUTPATIENT USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY 1G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY 1G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY 2G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY 2G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY THIRD-PARTY MANAGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY THIRD-PARTY MANAGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY MARKETPLACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 154. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 155. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 156. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 157. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 160. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 161. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 162. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 163. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 164. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 165. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 166. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 167. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 168. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 169. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. CANADA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ACUTE PELVIC INFECTIONS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED INTRA-ABDOMINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM ERTAPENEM SODIUM FOR INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ertapenem Sodium for Injection market report include:
  • Merck & Co., Inc.
  • Sandoz AG
  • Fresenius Kabi AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy’s Laboratories Limited
  • Lupin Limited
  • Sun Pharmaceutical Industries Limited

Related Topics

Related Reports

Ertapenem Sodium API Market - Global Forecast 2025-2030 - Product Image

Ertapenem Sodium API Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
4-AA for Carbapenem Antibiotic Market - Global Forecast 2025-2030 - Product Image

4-AA for Carbapenem Antibiotic Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Sodium Chloride Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sodium Chloride Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 107 Pages
  • Global
From
Bottled Sodium Chloride Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bottled Sodium Chloride Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 116 Pages
  • Global
From
Lactated Ringer`s Injection - Global Strategic Business Report - Product Image

Lactated Ringer`s Injection - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.